RBM26抗体;RBM26 Antibody—艾普蒂

+ +

•  

   

     The image is immunohistochemistry of paraffin-embedded Human esophagus cancer tissue using P13556(RBM26 Antibody) at dilution 1/35. (Original magnification: ×200)    

  
  

The RBM26 (RNA Binding Motif Protein 26) antibody is a tool used to study the RBM26 protein, a member of the RNA-binding protein family involved in post-transcriptional gene regulation. RBM26 contains RNA recognition motifs (RRMs) that enable interactions with RNA molecules, playing roles in splicing, stability, and translation of target RNAs. It is ubiquitously expressed, with higher levels observed in tissues like the brain, heart, and testes, suggesting tissue-specific regulatory functions. Dysregulation of RBM26 has been linked to diseases, including cancer and neurological disorders, though its precise mechanisms remain under investigation.

The RBM26 antibody is typically generated in hosts like rabbits or mice using immunogenic peptides or recombinant protein fragments. It is widely utilized in techniques such as Western blotting, immunoprecipitation, and immunofluorescence to detect RBM26 expression, localization, and interaction partners. Validation often includes knockdown experiments or mass spectrometry to confirm specificity. Researchers employ this antibody to explore RBM26's role in RNA metabolism, cellular stress responses, and disease pathways.

Current studies focus on RBM26's involvement in alternative splicing events and its potential as a biomarker or therapeutic target. However, challenges persist in fully elucidating its molecular networks and disease relevance. The antibody's utility continues to support advancements in understanding RNA-binding proteins' contributions to cellular homeostasis and pathology.